"Watchful Waiting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clinical management approach wherein immediate therapy is not provided but there is a period of observation during which periodic tests monitor patient and the progression of the illness. (Driffield T, Smith PC Med Decis Making. 2007 Mar-Apr;27(2):178-88)
Descriptor ID |
D057832
|
MeSH Number(s) |
N04.761.559.590.900
|
Concept/Terms |
Watchful Waiting- Watchful Waiting
- Waiting, Watchful
- Waitings, Watchful
- Watchful Waitings
|
Below are MeSH descriptors whose meaning is more general than "Watchful Waiting".
Below are MeSH descriptors whose meaning is more specific than "Watchful Waiting".
This graph shows the total number of publications written about "Watchful Waiting" by people in this website by year, and whether "Watchful Waiting" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2011 | 1 | 2 | 3 |
2012 | 1 | 1 | 2 |
2013 | 2 | 4 | 6 |
2014 | 4 | 1 | 5 |
2015 | 4 | 4 | 8 |
2016 | 2 | 1 | 3 |
2017 | 2 | 1 | 3 |
2018 | 1 | 4 | 5 |
2019 | 1 | 2 | 3 |
2020 | 1 | 0 | 1 |
2021 | 5 | 2 | 7 |
2022 | 1 | 7 | 8 |
2023 | 1 | 1 | 2 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Watchful Waiting" by people in Profiles.
-
Primary Care Physician and Urologist Perspectives on Optimizing Active Surveillance for Low-Risk Prostate Cancer. Ann Fam Med. 2024 Jan-Feb; 22(1):5-11.
-
Patient perspectives on factors influencing active surveillance adherence for low-risk prostate cancer: A qualitative study. Cancer Med. 2024 Jan; 13(1):e6847.
-
Risk Stratification of Low-risk Prostate Cancer: Individualizing Care in the Era of Active Surveillance. J Urol. 2023 07; 210(1):38-45.
-
Mindfulness-based stress reduction for men on active surveillance for prostate cancer and their spouses: Design and methodology of a randomized controlled trial. Contemp Clin Trials. 2023 02; 125:107059.
-
Selective Fetoscopic Laser Photocoagulation or Expectant Management for Stage I Twin-Twin Transfusion: A Cost-Effectiveness Analysis. Fetal Diagn Ther. 2022; 49(9-10):394-402.
-
Longitudinal assessment of quality of life in indolent non-Hodgkin lymphomas managed with active surveillance. Leuk Lymphoma. 2022 Dec; 63(14):3331-3339.
-
The (After)life of a Trial: Biocommunicability of an At-Risk Pregnancy. Med Anthropol. 2022 Nov-Dec; 41(8):794-809.
-
Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up. J Urol. 2022 07; 208(1):19-25.
-
Exploring Variation in the Receipt of Recommended Active Surveillance for Men with Favorable-Risk Prostate Cancer. J Urol. 2022 09; 208(3):600-608.
-
Diet and Health-related Quality of Life Among Men on Active Surveillance for Early-stage Prostate Cancer: The Men's Eating and Living Study (Cancer and Leukemia Group 70807 [Alliance]). Eur Urol Focus. 2022 11; 8(6):1607-1616.